| 000 | 01059 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516200806.0 | ||
| 264 | 0 | _c20140501 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a2326-5205 | ||
| 024 | 7 |
_a10.1002/art.38242 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuarez-Almazor, Maria E | |
| 245 | 0 | 0 |
_aReply: To PMID 23728826. _h[electronic resource] |
| 260 |
_bArthritis & rheumatology (Hoboken, N.J.) _cMar 2014 |
||
| 300 |
_a770 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 |
_aMonitoring, Physiologic _xmethods |
| 650 | 0 | 4 |
_aPatient Compliance _xstatistics & numerical data |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 773 | 0 |
_tArthritis & rheumatology (Hoboken, N.J.) _gvol. 66 _gno. 3 _gp. 770 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.38242 _zAvailable from publisher's website |
| 999 |
_c23590069 _d23590069 |
||